
|Articles|August 15, 2003
STAAR's ICL wins spot on FDA's fast-track list
Monrovia, CA-The FDA is studying STAAR Surgical Co.'s implantable contact lens (ICL) under an expedited review status that calls the product a potentially revolutionary advance over the current market.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement




























